Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study

BACKGROUND: There is little information regarding whether the combination of Helicobacter pylori (H. pylori) antibody and serum pepsinogen (sPG), which is a marker of the degree of atrophic gastritis, has a discriminatory ability for detecting incident gastric cancer. We examined this issue in a lon...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Epidemiological Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121431/
https://www.ncbi.nlm.nih.gov/pubmed/27265836
http://dx.doi.org/10.2188/jea.JE20150258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121431/
https://www.ncbi.nlm.nih.gov/pubmed/27265836
http://dx.doi.org/10.2188/jea.JE20150258

Ejemplares similares